Literature DB >> 12409402

Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.

L Martin Lagging1, Clementina E Garcia, Johan Westin, Rune Wejstål, Gunnar Norkrans, Amar P Dhillon, Magnus Lindh.   

Abstract

An enzyme immunoassay has recently been developed for the hepatitis C virus (HCV) core antigen. To evaluate the possible association between core antigen and HCV RNA levels with regards to the change in liver histology over time as well as study the effect of duration of storage on viral load results, sequential sera were analyzed from 45 patients with chronic HCV infection who had undergone two or more liver biopsies. A relatively strong association was found between the core antigen and HCV RNA concentrations (r(s) = 0.8), with a core antigen level of 1 pg/ml corresponding to approximately 1,000 IU/ml. All 42 sera with detectable HCV RNA at the time of the second biopsy had core antigen concentrations above 1 pg/ml, and the three sera without detectable HCV RNA had concentrations below 1 pg/ml. No association was found between HCV RNA or core antigen levels and the stage of fibrosis in biopsy samples, progression of fibrosis, necro-inflammatory grade, steatosis, genotype, alanine aminotransferase level, or alcohol consumption. A significant association was demonstrated between the storage time of the samples and both the HCV RNA and core antigen concentrations. The median log HCV RNA concentrations (international units/milliliter) were 3.92 for the sera obtained at the time of the first biopsy (median storage time, 13.0 years) and 4.41 for the sera obtained at the time of the second biopsy (median storage time, 6.6 years) compared to 5.96, the median for 102 different routine clinical patient samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409402      PMCID: PMC139660          DOI: 10.1128/JCM.40.11.4224-4229.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

Authors:  K Moriya; H Yotsuyanagi; Y Shintani; H Fujie; K Ishibashi; Y Matsuura; T Miyamura; K Koike
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

2.  Ordinal invariant measures for individual and group changes in ordered categorical data.

Authors:  E Svensson
Journal:  Stat Med       Date:  1998-12-30       Impact factor: 2.373

3.  Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.

Authors:  P Halfon; H Khiri; V Gerolami; M Bourliere; J M Feryn; P Reynier; A Gauthier; G Cartouzou
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

4.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.

Authors:  K Moriya; H Fujie; Y Shintani; H Yotsuyanagi; T Tsutsumi; K Ishibashi; Y Matsuura; S Kimura; T Miyamura; K Koike
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

5.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype.

Authors:  R B Ray; L M Lagging; K Meyer; R Ray
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

7.  Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

Authors:  L De Moliner; P Pontisso; G L De Salvo; L Cavalletto; L Chemello; A Alberti
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

8.  The stability of serum hepatitis C viral RNA in various handling and storage conditions.

Authors:  T L Fong; F Charboneau; B Valinluck; S Govindarajan
Journal:  Arch Pathol Lab Med       Date:  1993-02       Impact factor: 5.534

9.  Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein.

Authors:  R B Ray; L M Lagging; K Meyer; R Steele; R Ray
Journal:  Virus Res       Date:  1995-08       Impact factor: 3.303

10.  Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications.

Authors:  A Widell; S Shev; S Månsson; Y Y Zhang; U Foberg; G Norkrans; A Frydén; O Weiland; J Kurkus; E Nordenfelt
Journal:  J Med Virol       Date:  1994-11       Impact factor: 2.327

View more
  3 in total

1.  Monitoring treatment response by the hepatitis C virus core antigen assay.

Authors:  M Lindh; M Lagging; J Westin; R Wejstål; G Norkrans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

2.  Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.

Authors:  Masahiko Takahashi; Hidetsugu Saito; Makiko Higashimoto; Kazuhiro Atsukawa; Hiromasa Ishii
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 3.  Epidemiology and natural history of hepatitis C virus infection.

Authors:  Mei-Hsuan Lee; Hwai-I Yang; Yong Yuan; Gilbert L'Italien; Chien-Jen Chen
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.